23andMe

23andMe confirms hackers stole ancestry data on 6.9 million users
TechCrunch
Mon, 12/4/23 - 06:01 pm
23andMe
cybersecurity
hackers
CEO Anne Wojcicki on turning 23andMe into a ‘full-fledged biotech’
BioPharma Dive
Wed, 11/8/23 - 10:20 am
23andMe
biotech
Anne Wojcicki
23andMe Granted New FDA Clearance to Report Additional BRCA Variants
Drugs.com
Tue, 09/5/23 - 11:15 am
23andMe
BRCA
diagnostics
FDA
Why 23andMe Holding Stock Plummeted by 13% Today
Motley Fool
Wed, 08/9/23 - 10:00 pm
earnings
23andMe
diagnostics
genetics
23andMe doses first patient in ph2a anti-tumour monotherapy
Pharmaphorum
Wed, 03/1/23 - 09:48 am
23andMe
clinical trials
solid tumors
23ME-00610
23andMe CEO Anne Wojcicki on Bringing Health Information Directly to People
Motley Fool
Sat, 04/30/22 - 02:36 pm
23andMe
Medtech
diagnostics
Anne Wojcicki
consumers
The top 10 medtech M&A deals of 2021
Fierce Biotech
Tue, 01/18/22 - 10:35 am
devices
Medtech
M&A
Thermofisher
PPD
23andMe
PerkinElmer
BioLegend
Illumina
Grail
Baxter International
Hill-Rom
Steris
Cantel Medical
Siemens Healthineers
Varian Medical Systems
23andMe Keeps Snagging FDA Nods for Cancer Marker Tests
Medical Devices and Diagnostics Industry
Tue, 01/11/22 - 10:15 pm
23andMe
FDA
diagnostics
prostate cancer
cancer
23andMe Jumps into Telehealth with New M&A
Medical Devices and Diagnostics Industry
Sun, 10/24/21 - 10:34 pm
23andMe
diagnostics
M&A
Lemonaid Health
telehealth
23andMe Stock Could Be a Big Winner If This 1 Thing Happens
Motley Fool
Sun, 10/17/21 - 11:00 pm
23andMe
SPAC
diagnostics
4 takeaways from 23&Me’s planned SPAC deal
MedCity News
Mon, 02/8/21 - 10:37 am
diagnostics
23andMe
SPAC
23andMe to go public via Richard Branson’s SPAC
Stat
Thu, 02/4/21 - 10:40 am
23andMe
Richard Branson
SPAC
genetic testing
Early research from 23andMe strengthens link between blood types and Covid-19
Stat
Tue, 09/15/20 - 10:48 am
23andMe
blood types
COVID-19
genes
23andMe Is Trying to Crack the Genetic Code Behind the Coronavirus
Motley Fool
Tue, 05/19/20 - 10:32 am
23andMe
diagnostics
genomics
COVID-19
coronavirus
23andMe Lays Off 14% Of Workforce Amid Declining DNA Test Sales
Forbes
Thu, 01/23/20 - 11:48 pm
23andMe
layoffs
diagnostics
GSK bets on tech to help boost lagging R&D as it looks to start 23andMe trial
Fierce Biotech
Wed, 01/22/20 - 11:10 am
GSK
23andMe
R&D
Emma Walmsley
23andMe’s First Drug Candidate Licensed to Spanish Pharma Company
Xtalks
Tue, 01/14/20 - 11:26 pm
23andMe
diagnostics
Almirall
Ancestry launches consumer genetics tests for health, intensifying rivalry with 23andMe
Stat
Tue, 10/15/19 - 09:54 am
diagnostics
Ancestry
23andMe
DNA testing
home genetic testing
23andMe and GSK are mining customers’ DNA data in a hunt for new drugs
Marketwatch
Tue, 07/23/19 - 12:09 pm
23andMe
GSK
data
data mining
DNA
DNA testing
drug development
ethics
23andMe is moving into Apple’s territory with a pilot to pull in medical data, not just DNA
CNBC
Sun, 07/14/19 - 04:15 pm
23andMe
diagnostics
Apple
patients
medical data

Pages